Role of toll like receptors in the antibody response to encapsulated bacteria

Frontiers in Bioscience - Elite

Volumn 4 E, Issue 7, 2012, Pages 2638-2646

  Schreiber, John R ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antibodies; Glycoconjugate vaccines; Polysaccharide capsules; Review; T independent antigens; Toll like receptors

Indexed keywords

APRIL RECEPTOR; B CELL ACTIVATING FACTOR; BACTERIAL POLYSACCHARIDE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; MESSENGER RNA; MYELOID DIFFERENTIATION FACTOR 88; PNEUMOCOCCUS VACCINE; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR AGONIST; UNCLASSIFIED DRUG; BACTERIUM ANTIBODY; TUMOR NECROSIS FACTOR RECEPTOR;

ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIGEN PRESENTATION; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CELL DIFFERENTIATION; DENDRITIC CELL; HUMAN; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; MEMORY T LYMPHOCYTE; MONOCYTE; NONHUMAN; PNEUMOCOCCAL INFECTION; SPLEEN CELL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; BACTERIUM; BIOSYNTHESIS; CYTOLOGY; DRUG POTENTIATION; IMMUNOLOGY; PHYSIOLOGY; REVIEW;

BACTERIA (MICROORGANISMS);

ANTIBODIES, BACTERIAL; B-LYMPHOCYTES; BACTERIA; CELL DIFFERENTIATION; HUMANS; RECEPTORS, TUMOR NECROSIS FACTOR; TOLL-LIKE RECEPTORS;

EID: 84867300374     PISSN: 19450494     EISSN: 19450508     Source Type: Journal    
DOI: 10.2741/e571     Document Type: Article

References (56)

1. David Mills, John Cambier: B lymphocyte activation during cognate interactions with CD4+ T lymphocytes: molecular dynamics and immunologic consequences. Seminars in Immunol 15, 325-329 (2003) (Pubitemid 38160928)
2. James Mond, Quirijin Vos, Andrew Lees, Clifford Snapper: T cell independent antigens. Curr Opin Immunol 7,349-354 (1995)
3. Katherine Stein: Thymus-independent and thymusdependent responses to polysaccharide antigens. J Infect Dis 165, Suppl 1, S49-S52 (1992)
4. Elizabeth Adderson, Penelope Shackelford, William Carroll: Somatic hypermutation in T-independent and Tdependent immune responses to Haemophilus influenzae type b polysaccharide. Clin Immunol Immunopath 89, 240- 246 (1998) (Pubitemid 28565110)
5. Emanuela Castigli, Stepehn A. Wilson, Lilit Garibyan, Rima Rachid, Francisco Bonilla, Lynda Schneider, Raif Geha: TACI is mutant in common variable immunodeficiency. Nature Genetics 37, 829-834 (2005) (Pubitemid 41077108)
6. Gotz-Ulrich von Bulow, Jan M. van Deursen, Richard J. Bram: Regulation of the T-independent humoral response by TACI. Immunity 14, 573-582 (2001) (Pubitemid 32520868)
7. Emanuela Castigli, Stephen A. Wilson, Sumi Scott, Fatma Dedeoglu, Shengli Xu, Kong-Peng Lam, Richard J. Bram, Haifa Jabara, Raif Geha: TACI and BAFF-R mediate isotype switching in B cells. J Exp Med 201, 35-39 (2005) (Pubitemid 40130081)
8. Sunita Kansal, Nora Katsenelson, Windy Allman, Kadriye Uslu, Milan Blake, Mustafa Akkoyunlu: Suppressive effect of bacterial polysaccharides on BAFF system is responsible for their poor immunogenicity. J Immunol 186, 2430-2443 (2011)
9. Sunita Kanswal, Nora Katsenelson, Angamuthu Selvapandiyan, Richard J. Bram and Mustafa Akkoyunlu: Deficient TACI expression on B lymphocytes of newborn mice leads to defective Ig secretion in response to BAFF and APRIL. J Immunol 181, 976-990 (2008)
10. Kulwant Kaur, Shimul Chowdhury, Neil Greenspan and John R. Schreiber: Decreased expression of tumor necrosis factor family receptors involved in humoral immune responses in preterm neonates. Blood 110, 2948-2954 (2007) (Pubitemid 350006948)
11. Marcus Dorner, Simone Brandt, Marianne Tinguely, Franziska Zucol, Jean-Pierre Bourquin, Ludwig Zauner, Christoph Berger, Michele Bernasconi, Roberto Speck, David Nadal: Plasma cell toll-like receptor (TLR) expression differs from that of B cells, and plasma cell TLR triggering enhances immunoglobulin production. Immunol 128, 573-579 (2009)
12. Nadia Bernasconi, Nobuyuki Onai, Antonio Lanzavecchia: A role for toll-like receptors in acquired immunity: up regulation of TLR9 by BCR triggering in naïve B cells and constitutive expression in memory B cells. Blood 101, 4500-4504 (2003) (Pubitemid 36857820)
13. Claudia Ruprecht, Antonio Lanzaveccia: Toll-like receptor stimulation as a third signal required for activation of human naïve B cells. Eur J Immunol 36, 810-816 (2006)
14. Isabelle Bekeredjian-Ding, Gaetan Jego: Toll-like receptors-Sentries in the B cell response. Immunol 128, 311-323 (2009)
15. Flavius Martin, Alyce Oliver, John Kearney: Marginal zone and B1 B cells unite in the early response against Tindependent blood-borne particulate antigens. Immunity 14, 617-629 (2001) (Pubitemid 32520872)
16. Goutam Sen, Abdul Khan, Quanyi Chen, Clifford Snapper: In vivo humoral immune responses to isolated pneumococcal polysaccharides are dependent on the presence of associated TLR ligands. J Immunol 175, 3084- 3091 (2005) (Pubitemid 41170528)
17. A Zandvoort, W Timens: The dual function of the splenic marginal zone: essential for the initiation of anti-TI- 2 responses but also vital in the general first line defense against blood-borne pathogens. Clin Exp Immunol 130, 4- 11 (2002)
18. Lai Guan Ng, Chee-Hoe Ng, Blanche Woehl, Andrew Sutherland, Jianxin Huo, Shengli Xu, Fabienne Mackay, Kong-Peng Lam: BAFF costimulation of Toll-like receptor activated B-1 cells. Eur J Immunol 36, 1837-1846 (2006) (Pubitemid 44089050)
19. Egest Pone, Hong Zan, Jinsong Zhang, Ahmed Al- Qahtani, Zhenming Xu, Paolo Casali: Toll-like receptors and B-cell receptors synergize to induce immunoglobulin class-switch DNA recombination: Relevance to microbial antibody responses. Crit Rev Immunol 30, 1-29 (2010)
20. Nora Katsenelson, Sunita Kanswal, Montserrat Puig, Howard Mostowski, Daniela Verthelyi, Mustafa Akkoyunlu: Synthetic CpG oligodeoxynucleotides augment BAFF- and APRIL-mediated immunoglobulin secretion. Eur J Immunol 37, 1785-1795 (2007) (Pubitemid 47065118)
21. Stefan Borsutzky, Karsten Kretschmer, Pablo Becker, Peter Muhlradt, Carsten Kirschning, Siegfried Weiss, Carlos Guzman: The mucosal adjuvant macrophageactivating lipopeptide-2 directly stimulates B lymphocytes via the TLR2 without the need of accessory cells. J Immunol 174, 6308-6313 (2005) (Pubitemid 40663823)
22. Cristina Swanson, Timothy Wilson, Pamela Strauch, Marco Colonna, Roberta Pelanda, Raul Torres: Type I IFN enhances follicular B cell contribution to the T cellindependent antibody response. J Exp Med 207, 1485-1500 (2010)
23. Danilo Escobar, Jaime Pons, Antonio Clemente, Julio Iglesias, Veronica Regueiro, Jose Bengoechea, Nuria Matamoros, Joana Ferrer: Defective B cell response to TLR9 ligand (CPG-ODN), Streptococcus pneumoniae and Haemophilus influenzae extracts in common variable immune deficiency. Cellular Immunol 262, 105-111 (2010)
24. Kulwant Kaur, Christopher King, Neil Greenspan, H. Lester Kirchner, John Schreiber: Immunization with Haemophilus influenzae type b-CRM197 conjugate vaccine elicits a mixed Th1 and Th2 CD4+ T cell cytokine response that correlates with the isotype of antipolysaccharide antibody. J Infect Dis 184, 931-935 (2001) (Pubitemid 32881102)
25. Hilde-Kari Guttormsen, Arlene Sharpe, Anil Chandraker, Anne Karin Brigtsen, Mohammed Sayegh, Dennis Kasper: Cognate stimulatory B-cell-T-cell interactions are critical for T-cell help recruited by glycoconjugate vaccines. Infect and Immun 67, 6375-6384 (1999)
26. Zeng Zu Lai, John Schreiber: Antigen processing of glycoconjugate vaccines; the polysaccharide portion of the pneumococcal CRM197 conjugate vaccine co-localizes with MHC II on the antigen processing cell surface. Vaccine 27, 3137-3144 (2009)
27. Steven Black, Henry Shinefield, Bruce Fireman, Robert Hiatt, Michael Polen, Eric Vittinghoff: Efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in a United States population of 61,080 children. Pediatr Infect Dis J 10, 97-104 (1991)
28. Margaret Rennels, Kathryn Edwards, Harry Keyserling, Keith Reisinger, Deborah Hogerman, Dace Madore, Ih Chang, Peter Paradiso, Frank Malinoski, Alan Kimura: Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM197 in United States infants. Pediatrics 101, 604-611 (1998) (Pubitemid 28180141)
29. Matthew Snape, Kirsten Perrett, Karen Ford, Tessa John, David Pace, Ly-Mee Yu, Joanne Langley, Shelley McNeil, Peter Dull, Francesca Ceddia, Alessandra Anemona, Scott Halperin, Simon Dobson, Andrew Pollard: Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants: A randomized controlled trial. JAMA 299, 173-184 (2008)
30. Katherine Hsu, Kimberly Shea, Abbie Stevenson, Stephen Pelton: Changing serotypes causing childhood invasive pneumococcal disease; Massachusetts, 2001-2007. Pediatr Infect Dis J 29, 289-293 (2010)
31. Susan Huang, Virginia Hinrichsen, Abbie Stevenson, Sheryl Rifas-Shiman, Ken Kleinman, Stephen Pelton, Marc Lipsitch, William Hanage, Grace Lee, Jonathan Finkelstein: Continued impact of pneumococcal vaccine on carriage in young children. Pediatrics 124, e1-e11 (2009)
32. Wendy Hutchins, Geoarge Carlone MA Julie Westerink: Elderly immune response to a TI-2 antigen: Heavy and light chain use and bactericidal activity to Neisseria meningitidis serogroup C polysaccharide. J Infect Dis 179, 1433-1440 (1999) (Pubitemid 29246593)
33. Andrew Artz, William Ershler, Dan Longo: Pneumococcal vaccination and revaccination of older adults: Clin Microbiol Rev 16, 308-18 (2003) (Pubitemid 36519814)
34. Andres de Roux, B. Schmoele-Thoma, George Siber, J G Hackell, A Kuhnke, N Ahlers, SA Baker, A Razmpour, EA Emini, PD Feinstein, WC Gruber, S Lockhart, O Burkhardt, T Welte, HM Lode: Comparison of pneumococcal conjugate polysaccharide and free polysaccharide in elderly adults: Conjugate vaccine elicits improved antibacterial immune responses and immunological memory. Clin Infect Dis 46, 1015-1023 (2008) (Pubitemid 351589866)
35. Mary Renshaw, Julie Rockwell, Andrew Gewirtz, Jacqueline Katz, Suryaprakash Sambhara: Impaired tolllike receptor expression and function in aging: J Immunol 169, 4697-4701 (2002) (Pubitemid 35217128)
36. Karen Miernyk, Jay Butler, Lisa Bulkow, Rosalyn Singleton, Thomas Hennessy, Catherine Dentinger, Helen Peters, Barbara Knutsen, Jack Hickel, Alan Parkinson: Immunogenicity and reactogenicity of pneumococcal polysaccharide and conjugate vaccines in Alaska native adults 55-70 years of age. Clin Infect Dis 49, 241-248 (2009)
37. I. Ridda, C. MacIntyre, R. Lindley, Z. Gao, J. Sullivan, F. Yuan, P. McIntyre: Immunological responses to pneumococcal vaccine in frail older people. Vaccine 27, 1628-1636 (2009)
38. Abdul Khan, Quanyi Chen, Zheng-Qi Wu, James Paton, Clifford Snapper: Both innate and type 1 humoral immunity to Streptococcus pneumoniae are mediated by MyD88 but differ in their relative levels of dependence on toll-like receptor 2. Infect and Immun 73, 298-307 (2005) (Pubitemid 40041121)
39. Sam Vasilevsky, Gouri Chattopadhyay, Jesus Colino, Tze-Jou Yeh, Quanyi Chen, Goutam Sen, Clifford Snapper: B and CD4+ T-cell expression of TLR2 is critical for optimal induction of a T-cell-dependent humoral immune response to intact Streptococcus pneumoniae. Eur J Immunol 38, 3316-3326 (2008)
40. Deborah Threadgill, Linda McCormick, Tera McCool, Neil Greenspan, John Schreiber: Mitogenic synthetic polynucleotides suppress the antibody response to a bacterial polysaccharide. Vaccine 16, 76-82 (1998) (Pubitemid 27504808)
41. Morgan Taillardet, Ghina Haffar, Paul Mondiere, Marie-Jeanne Asensio, Thomas Pleau-Pison, Nicolas Burdin, Thierry Defrance, Laurent Genestier: Toll-like receptor agonists allow generation of long-lasting antipneumococcal humoral immunity in response to a plain polysaccharide vaccine. J Infect Dis 202, 470-479 (2010)
42. Porter Anderson: Antibody responses to Haemophilus influenzae type b and diphtheria toxin induced by conjugates of oligosaccharides of the type b capsule with the nontoxic protein CRM197. Infect and Immun 39, 233- 238 (1983) (Pubitemid 13212521)
43. Dan Granoff, Sandra Holmes: Comparative immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugate vaccines. Vaccine 9, S30- 34 (1991)
44. Paoli Massari, Philipp Henneke, Yu Ho, Eicke Latz, Douglas Golenbock, Lee Wetzler: Immune stimulation by neisserial porins is toll-like receptor 2 and MyD88 dependent. J Immunol 168, 1533-1537 (2002) (Pubitemid 34135744)
45. Eicke Latz, Jennifer Francko, Douglas T. Golenbock, John R. Schreiber: Haemophilus influenzae type b-outer membrane protein complex glycoconjugate vaccine induces cytokine production by engaging human toll-like receptor 2 (TLR2) and requires the presence of TLR2 for optimal immunogenicity. J Immunol 172, 2431-2438 (2004) (Pubitemid 38182392)
46. Zengzu Lai, John Schreiber: Outer membrane protein complex from meningococcus enhances the antipolysaccharide antibody response to pneumococcal CRM197 conjugate vaccine. Clin Vaccine Immunol 18, 724- 729 (2011)
47. John McLay, Ethan Leonard, Sheryl Petersen, David Shapiro, Neil Greenspan, John Schreiber: 3 gene-disrupted mice selectively deficient in the dominant IgG subclass made to bacterial polysaccharides. II. Increased susceptibility to fatal pneumococcal sepsis due to absence of anti-polysaccharide IgG3 is corrected by induction of anti-polysaccharide IgG1. J Immunol 168, 3437-3443 (2002) (Pubitemid 34250408)
48. Roger Perlmutter, Daniel Hansburg, David Briles, Robert Nicolotti, Joseph Davie: Subclass restriction of murine anti-carbohydrate antibodies: J Immunol 121, 566- 572 (1978) (Pubitemid 8397246)
49. Penelope Shackelford, Dan Granoff, Susan Nelson, Mitchell Scott, Daniel Smith, Moon Nahm: Subclass distribution of human antibodies to Haemophilus influenzae type b capsular polysaccharide. J Immunol 138, 587-592 (1987) (Pubitemid 17002225)
50. Rose S. Chu, Tera McCool, Neil S. Greenspan, John R. Schreiber, Clifford V. Harding: CpG oligodeoxynucleotides act as adjuvants for pneumococcal polysaccharide-protein conjugate vaccines and enhance anti-polysaccharide immunoglobulin G2a and IgG3 antibodies. Infect and Immun 68, 1450-1456 (2000) (Pubitemid 30108543)
51. Goutam Sen, Quanyi Chen, Clifford Snapper: Immunization of aged mice with a pneumococcal conjugate vaccine combined with an unmethylated CpG-containing oligodeoxynucleotide restores defective immunoglobulin G antipolysaccharide responses and specific CD4+-T-cell priming to young adult levels. Infect and Immun 74, 2177- 2186 (2006)
52. Floris Fransen, Claire Boog, Jos van Putten, Peter van der Ley: Agonists of toll-like receptors 3, 4, 7, and 9 are candidates for use as adjuvants in an outer membrane vaccine against Neisseria meningitidis serogroup B. Infect and Immun 75, 5939-5946 (2007) (Pubitemid 350207834)
53. Qibo Zhang, Linda Bagrade, Ed Clarke, James C. Paton, Desmond A. Nunez, Adam Finn: Bacterial lipoproteins differentially regulate human primary and memory CD4+ T and B cell responses to pneumococcal protein antigens through toll-like receptor 2. J Infect Dis 201, 1753-1763 (2010)
54. Jamie Croxtall, Gillian Keating: Pneumococcal polysaccharide protein D-conjugate vaccine (Synflorix; PhiDCV) Pediatr Drugs 11, 349-357 (2009)
55. Hila Amir-Kroll, Gabriel Nussbaum, Irum Cohen: Proteins and their derived peptides as carriers in a conjugate vaccine for Streptococcus pneumoniae: Self-heat shock protein 60 and tetanus toxoid: J Immunol 170, 6165-6171 (2003) (Pubitemid 36682600)
56. Markus Knuf, Frank Kowalzik, Dorothee Lieninger: Comparitive effects of carrier proteins on vaccine-induced immune response: Vaccine 29, 4881-4890 (2011)